MIDD0301 sodium
MIDD0301 (GL-II-93) sodium is an orally active inhibitor of γ-aminobutyric acid type A receptors (GABAAR) and an anti-asthmatic agent. It shows bio- and immunotoxicological safety in mice without affecting circulating lymphocyte, monocyte, and granulocyte counts. MIDD0301 sodium demonstrates no significant adverse immune responses under repeated dosing and is more favorable than Prednisone. It relaxes histamine-contracted tracheal smooth muscle in guinea pigs and humans, making it a valuable candidate for research in bronchoconstriction-related diseases.
Product Specifications
CAS Number
2593569-36-7
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Smiles
C (O) (=O) C1=C2N (C=3C (C (=N[C@@H]2C) C4=C (F) C=CC=C4) =CC (Br) =CC3) C=N1.[Na]
Molecular Formula
C19H13BrFN3NaO2
Molecular Weight
437.218
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
RUNX2 (Runt-Related Transcription Factor 2, AML3, CBFA1, CCD, CCD1, MGC120022, MGC120023, OSF2, PEA2aA, PEBP2A1, PEBP2A2, PEBP2aA, PEBP2aA1) (PE)
RUNX2 (Runt-Related Transcription Factor 2, AML3, CBFA1, CCD, CCD1, MGC120022, MGC120023, OSF2, PEA2aA, PEBP2A1, PEBP2A2, PEBP2aA, PEBP2aA1) (PE)
